The largest database of trusted experimental protocols

51 protocols using cd45 percp cy5

1

Comprehensive Immunophenotyping of Splenic NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, splenic NK cells were stained with CD3-PE-Cy7 (clone 145-C211, BD Biosciences, Franklin Lakes, NJ), NK1.1-PerCP-Cy5.5 (clone PK136, BD Biosciences), Ly49A-PE (clone A1, BD Biosciences), Ly49C/I-FITC (clone 5E6, BD Biosciences), Ly49D-BV510 (clone 4E5, BD Biosciences), and Ly49G2-APC (clone 4D11, BD Biosciences) to assess Ly49 receptor expression. To detect NKG2D expression, a separate cell preparation was stained with CD3, NK1.1, and NKG2D-APC (clone CX5, BioLegend). After isolation post-transplantation, allograft endothelial cells were stained with CD45-PerCP-Cy5.5 (clone 104, BD Biosciences), CD31-FITC (clone 390, Invitrogen), Rae-1-BV421 (clone 186107, BD Biosciences), H60-PE (clone 205326, R&D Systems (Minneapolis, MN)), and MULT-1-APC (clone 237104, R&D systems). To detect anti-donor MHC Class I antibody bonding, naïve endothelial cells were stained with CD45-PerCP-Cy5.5 (clone 104, BD Biosciences), CD31-PE (clone 390, BioLegend), and mouse IgG-FITC (clone poly 4060, BioLegend) after incubation with the appropriate monoclonal antibody. After staining, cells were washed twice with PBS with 1% bovine serum albumin (BSA) and 0.1% sodium azide; data was collected using a BD LSR II or BD Fortessa flow cytometer (BD Biosciences) and analyzed with FlowJo software (BD Biosciences, Version 10.6.2).
+ Open protocol
+ Expand
2

Quantitative Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stained cells were analyzed using a BD LSR II-SORP or Fortessa system (Becton Dickinson) and analyzed with FlowJo software (Tree Star). The following anti-mouse mAbs were used: CD45- PerCPCy5, CD45-APC, CD8-APC, anti-IFNγ-PECy7, and anti-IL-4-FITC (BD Biosciences), CD4-AF700, CD11b APC-eFluor780, and c-kit PECy7 all from (eBiosciences). Anti human CD2 (BioLegend) was used to detect IL-4 production in KN2 mice. To detect IL-4Rα on primary keratinocytes, the following anti-mouse mAbs were used: CD124, anti IL-4Rα-PE (BD, Pharmingen), and CD49f-Brillant Violet 421 (BioLegend). Imaging flow cytometry was performed using an ImageStream cytometer (Amnis, Millipore) at low speed. Data were analyzed with the IDEAS software.
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stained cells were analyzed using a BD LSR II-SORP system (Becton Dickinson) and analyzed with FlowJo software (Tree Star). The following mAbs were used: CD45-PerCPCy5, CD45-APC, CD8-APC, anti-IFNγ-PECy7 and anti-IL-4-FITC (BD Biosciences), Gr1-APC, CD11c-PECy7, CD11b-PB, F4/80-APC (eBiosciences), 1A8-APCCy7, Ly6C-FITC, 1A8-APCCy7, CD4-AF700. DAPI and AnV-FITC (BioLegends). In vivo bioluminescence imaging of MPO activity was quantified through injection of 200mg/kg luminol (Carbosynth) i.p. 10 minutes before luminescence acquisition. Photon emission was acquired for 10 minutes using a Xenogen IVIS Imaging system.
+ Open protocol
+ Expand
4

Progenitor Cell Characterization in BMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was applied to determine the frequency of immature hematopoietic stem cells (CD34+/CD133+/CD45+), more mature progenitor cells (CD34+/CD133−/CD45+), and putative MSC-precursors (CD271+/CD45−) in the BMC preparations prior to the seeding procedure as well as in the supernatant after the seeding procedure to determine whether these cell types differ in their adhesive capacity to the scaffolds. Increased adhesion to the scaffold would result in a decreased percentage of that progenitor cell species in the fraction of nonadhering cells and a decreased adhesion to the scaffold would cause a relative increase of that progenitor cell species in the fraction of the nonadhering cells.
5 × 105 BMC were suspended in 100 μL PBS and were incubated for 30 minutes at 4°C with 10 μL of each CD34-FITC (BD-Biosciences, Heidelberg, Germany), CD133-PE (Miltenyi-Biotech, Bergisch-Gladbach, Germany), CD45-PerCP-Cy5 (BD-Biosciences), and CD271-APC (RnD-Systems, Wiesbaden, Germany). Fluorochrome conjugated isotype identical antibodies served as control. After incubation, the cells were washed twice and immediately analyzed by flow cytometry. 1 × 105 mononuclear cells were acquired based on their forward and side scatter properties.
+ Open protocol
+ Expand
5

Cell Surface Marker Expression Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
We analyzed cell surface expression with a pre-defined set of protein markers. These
assays were performed using commercially available monoclonal antibodies, following the
manufacturers’ instructions. Briefly, the cells at third passage were harvested by a
treatment with 0.25% Tryple Express (Gibco-Invitrogen, Carlsbad, CA, USA), washed with PBS
(pH = 7.4) and stained with the selected monoclonal antibodies and incubated in the dark
for 30 min at 4°C. Cells were then washed and fixed with 1% paraformaldehyde. The
following human antibodies were used: CD14-FITC (clone: M5E2; BD Pharmingen, San Diego,
CA, USA), CD29-PE (clone: MAR4; BD Pharmingen), CD31-PE (clone: WM59; BD Pharmingen),
CD34-PE (clone: 581; BD Pharmingen), CD44-PE (clone: 515; BD Pharmingen), CD45-PerCPCy5
(clone: 2D1; BD Biosciences, San Jose, CA, USA), CD73-PE (clone: AD2; BD Pharmingen),
CD90-APC (clone: 5E10; BD Pharmingen), CD106-FITC (clone: 51-10C9; BD Pharmingen),
CD166-PE (clone: 3A6; BD Pharmingen), HLA-DR-PerCP-Cy5 (clone: L243; BD Biosciences), and
CD105-PE (clone: 8E11; Chemicon, Temecula, CA, USA). Cells were analyzed using FACSARIA
flow cytometry equipment (BD Biosciences) and data analyses were performed using FACSDIVA
software (BD Biosciences) or Flow Jo Software (TreeStar, Ashland, OR, USA).
+ Open protocol
+ Expand
6

Immunophenotypic Characterization of ADSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADSCs and IGF-1-ADSCs were subjected to immunophenotypic characterization. Cultured ADSCs were harvested with 0.25% trypsin and suspended as single cells at a concentration of 5 × 10 5 cells in 500 µl PBS (10 mM, pH 7.4). To verify that cultured cells were MSCs, the cells were analyzed by flow cytometry (FACSCanto; BD Biosciences, Franklin Lakes, NJ, USA) after labeling with CD45-PercP-CY5 (BD Pharmingen™, San Diego, CA, USA), CD34-PE (Santa Cruz Biotechnology, Dallas, TX, USA), CD11b-FITC (Caltag Laboratories, Burlingame, CA, USA), CD29-FITC (BD Pharmingen), and CD90-FITC (Caltag Laboratories). Isotype IgG1 immunoglobulin served as a control. In addition, these cells were cultured in the presence of osteogenic medium [10 nM dexamethasone, 10 mM b-glycerophosphate, 50 µg/ml l-ascorbate 2-phospate, and 10 nM 1a,25-dihydroxyvitamin D 3 (all from BIOMOL Research Laboratories Inc., Plymouth Meeting, PA, USA)] and adipogenic medium [DMEM-low glucose supplemented with 15% fetal calf serum (FCS), 50 U/ml penicillin, 50 mg/ml streptomycin, 5 × 10 -4 M indomethacin, 10 µg/ml human insulin, and 10 -7 M dexamethasone (all from Sigma-Aldrich)].
+ Open protocol
+ Expand
7

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibodies CD3e-ApcCy7, CD45-PerCPCy5.5, Gr1-APC, CD8-PECy7, CD25-FITC, CD11b-FITC, CD11C-PE, B220-PB, and NK1.1-PE were purchased from BD Biosciences. Foxp3-APC and F4/80-PE were purchased from eBioscience and CD4-PO and calcein violet from Invitrogen.
+ Open protocol
+ Expand
8

Profiling HIV Reservoir Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was processed to obtain PBMC by density gradient separation. PBMCs were cryopreserved in aliquots of at least 5 × 106 cells and were later viably thawed for nucleic acid extraction and flow cytometric assessment. Baseline samples (study month 0) were not available due to usage in prior studies [38 (link),39 (link)]. For flow cytometry, approximately 0.2 × 106 PBMCs were stained with CD4+–FITC, CD8+–PE, CD45–PerCP-Cy5.5 and CD3–APC (BD Biosciences, San Diego, California, USA) and acquired in an Accuri flow cytometer (BD Biosciences, San Diego, CA, USA) to assess the percentage of CD4+ T cells in each sample. Next, DNA and RNA were dually extracted from the remaining sample using an AllPrep DNA/RNA Mini Kit (Qiagen, Germantown, Maryland, USA). Levels of HIV DNA were measured by ddPCR in triplicate using an extensively validated assay [40 (link)] with gag and 2-LTR-specific primers, normalized to a standard host DNA marker (RPP30). HIV ca-RNA was also measured by ddPCR, as previously described [40 (link)] using primer/probe sets for unspliced (gag usRNA), multispliced (tat-rev msRNA) and all fully elongated and correctly processed HIV mRNA molecules (polyA mRNA) [41 (link)]. HIV DNA and cell-associated RNA (ca-RNA) values were normalized by percentage of CD4+ T cells, as determined by flow cytometry.
+ Open protocol
+ Expand
9

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The proportions of neutrophils, lymphocytes, monocytes, CD4+ T, CD8+ T, CD19+ B, NK (CD3-CD56+), and NKT (CD3+CD56+) cell were analyzed by flow cytometry. The absolute counts of immune cells were measured by using BD TruCount Absolute-Count Tubes (BD340334). The following antibodies (CD3-FITC, CD8-APC-Cy7, CD4-PE-Cy7, CD45-Percp-Cy5.5, CD56-PE, and CD19-APC) were used, and all reagents were purchased from BD Biosciences. All samples were detected by a BD FACS Canto II flow cytometry system and analyzed with the BD FACS Diva software.
+ Open protocol
+ Expand
10

Multiparametric Flow Cytometry for Lymphocyte Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the same time as serological testing, whole blood draws for flow cytometry analysis (3 mL/subject) were collected in ethylenediaminetetraacetic acid (EDTA) tubes. The BD Multitest 6-color TBNK reagent was used to determine absolute counts of B and NK, as well as CD4 and CD8 subpopulations of T cells. The panel for staining included the following monoclonal antibodies: CD3 FITC, CD4 PE-Cy7, CD8 APC-Cy7, CD19 APC, CD45 PerCP-Cy5.5, and CD16 PE + CD56 PE; BD Biosciences, San Jose, CA). The BD Trucount tubes (BD Biosciences, San Jose, CA) were filled with 20 µL of BD Multitest 6-color TBNK reagent and 50 µL aliquots of EDTA-anticoagulated whole blood. The mixture was incubated at room temperature in the dark for 20 min before being lysed with 2 mL of FACS Lysis Solution (BD Biosciences, San Jose, CA). After an additional 15 min of incubation, the erythrocyte-lysed, unwashed, and stained samples were analyzed. The data were acquired using the BD FACSCanto II system and BD FACSCanto clinical software (BD Biosciences, San Jose, CA). The calibration of the instrument with BD FACS 7-color setup beads was confirmed before each running process according to the manufacturer’s instructions [16] . The results for each lymphocyte subset were reported as absolute cell counts/µL.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!